Clinical islet xenotransplantation: How close are we?

Diabetes

Volumn 61, Issue 12, 2012, Pages 3046-3055

  Van Der Windt, Dirk J ^a   Bottino, Rita ^a,b   Kumar, Goutham ^a   Wijkstrom, Martin ^a   Hara, Hidetaka ^a   Ezzelarab, Mohamed ^a   Ekser, Burcin ^a,c   Phelps, Carol ^d   Murase, Noriko ^a   Casu, Anna ^e   Ayares, David ^d   Lakkis, Fadi G ^a   Trucco, Massimo ^b   Cooper, David K C ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^c UNIVERSITY OF CATANIA   (Italy)

^d REVIVICOR INC   (United States)

^e MEDITERRANEAN INSTITUTE FOR TRANSPLANTATION AND ADVANCED SPECIALIZED THERAPIES ISMETT   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; C PEPTIDE; C REACTIVE PROTEIN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GALACTOSYLGALACTOSE; GLUTAMATE DECARBOXYLASE 65; GLUTAMATE DECARBOXYLASE 67; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PROINSULIN; TACROLIMUS;

ADAPTIVE IMMUNITY; AGE; ALLOTRANSPLANTATION; AMYLOIDOSIS; APOPTOSIS; AUTOIMMUNITY; B LYMPHOCYTE; CELL VIABILITY; DISEASE COURSE; GENE EXPRESSION; GENETIC ENGINEERING; GLUCOSE METABOLISM; GRAFT SURVIVAL; HEMODIALYSIS; HUMAN; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; ISLET XENOTRANSPLANTATION; KIDNEY TRANSPLANTATION; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; T LYMPHOCYTE; XENOTRANSPLANTATION;

ANIMALS; DIABETES MELLITUS, TYPE 1; HUMANS; ISLETS OF LANGERHANS TRANSPLANTATION; SWINE; TRANSPLANTATION, HETEROLOGOUS;

EID: 84870344926     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db12-0033     Document Type: Review

References (74)

1. Nathan DM, Cleary PA, Backlund JY, et al.; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005;353:2643-2653 (Pubitemid 41817713)
2. Collaborative Islet Transplant Registry. Sixth Annual Report. 1 November 2009. Available from http://www.citregistry.com/. Accessed 29 July 2011
3. Shapiro AM. State of the art of clinical islet transplantation and novel protocols of immunosuppression. Curr Diab Rep 2011;11:345-354
4. Thompson DM, Meloche M, Ao Z, et al. Reduced progression of diabetic microvascular complications with islet cell transplantation compared with intensive medical therapy. Transplantation 2011;91:373-378
5. US Department of Health & Human Services. Organ Procurement and Transplantation Network. Available from http://optn.transplant.hrsa.gov/ latestData/step2.asp? Accessed 29July 2011
6. Groth CG, Korsgren O, Tibell A, et al. Transplantation of porcine fetal pancreas to diabetic patients. Lancet 1994;344:1402-1404 (Pubitemid 24365315)
7. Valdés-González RA, Dorantes LM, Garibay GN, et al. Xenotransplantation of porcine neonatal islets of Langerhans and Sertoli cells: a 4-year study. Eur J Endocrinol 2005;153:419-427 (Pubitemid 41410499)
8. Elliott RB; Living Cell Technologies. Towards xenotransplantation of pig islets in the clinic. Curr Opin Organ Transplant 2011;16:195-200
9. First WHO Global Consultation on Regulatory Requirements for Xenotransplantation Clinical Trials: Changsha, China, 19-21 November 2008. The Changsha Communiqué. Xenotransplantation 2009;16:61-63
10. Hering BJ, editor. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes. Xenotransplantation 2009;16:196-262
11. Dufrane D, Goebbels RM, Gianello P. Alginate macroencapsulation of pig islets allows correction of streptozotocin-induced diabetes in primates up to 6 months without immunosuppression. Transplantation 2010;90:1054-1062
12. Moberg L, Johansson H, Lukinius A, et al. Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation. Lancet 2002;360:2039-2045 (Pubitemid 36026584)
13. Johansson H, Lukinius A, Moberg L, et al. Tissue factor produced by the endocrine cells of the islets of Langerhans is associated with a negative outcome of clinical islet transplantation. Diabetes 2005;54:1755-1762 (Pubitemid 40770765)
14. Ozmen L, Ekdahl KN, Elgue G, Larsson R, Korsgren O, Nilsson B. Inhibition of thrombin abrogates the instant blood-mediated inflammatory reaction triggered by isolated human islets: possible application of the thrombin inhibitor melagatran in clinical islet transplantation. Diabetes 2002;51:1779-1784 (Pubitemid 34564290)
15. Ji M, Yi S, Smith-Hurst H, et al. The importance of tissue factor expression by porcine NICC in triggering IBMIR in the xenograft setting. Transplantation 2011;91:841-846
16. Good AH, Cooper DK, Malcolm AJ, et al. Identification of carbohydrate structures that bind human antiporcine antibodies: implications for discordant xenografting in humans. Transplant Proc 1992;24:559-562
17. Rayat GR, Rajotte RV, Hering BJ, Binette TM, Korbutt GS. In vitro and in vivo expression of Galalpha-(1,3)Gal on porcine islet cells is age dependent. J Endocrinol 2003;177:127-135 (Pubitemid 36592593)
18. Bennet W, Sundberg B, Lundgren T, et al. Damage to porcine islets of Langerhans after exposure to human blood in vitro, or after intraportal transplantation to cynomologus monkeys: protective effects of sCR1 and heparin. Transplantation 2000;69:711-719 (Pubitemid 30174086)
19. Goto M, Tjernberg J, Dufrane D, et al. Dissecting the instant blood-mediated inflammatory reaction in islet xenotransplantation. Xenotransplantation 2008;15:225-234
20. van der Windt DJ, Marigliano M, He J, et al. Islet damage after direct exposure of pig islets to blood: has humoral immunity been underestimated? Cell Transplant 5 July 2012 [Epub ahead of print]
21. Mohanakumar T, Narayanan K, Desai N, et al. A significant role for histocompatibility in human islet transplantation. Transplantation 2006;82:180-187 (Pubitemid 44126814)
22. Thompson P, Badell IR, Lowe M, et al. Islet xenotransplantation using galdeficient neonatal donors improves engraftment and function. Am J Transplant 2011;11:2593-2602
23. Padler-Karavani V, Varki A. Potential impact of the non-human sialic acid N-glycolylneuraminic acid on transplant rejection risk. Xenotransplantation 2011;18:1-5
24. Hering BJ, Wijkstrom M, Graham ML, et al. Prolonged diabetes reversal after intraportal xenotransplantation of wild-type porcine islets in immunosuppressed nonhuman primates. Nat Med 2006;12:301-303 (Pubitemid 43355076)
25. Kawai T, Andrews D, Colvin RB, Sachs DH, Cosimi AB. Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand. Nat Med 2000;6:114 (Pubitemid 30082329)
26. Hilbrands R, Huurman VA, Gillard P, et al. Differences in baseline lymphocyte counts and autoreactivity are associated with differences in outcome of islet cell transplantation in type 1 diabetic patients. Diabetes 2009;58:2267-2276
27. Harrison LC, De Aizpurua H, Loudovaris T, et al. Reactivity to human islets and fetal pig proislets by peripheral blood mononuclear cells from subjects with preclinical and clinical insulin-dependent diabetes. Diabetes 1991;40:1128-1133
28. Cooper DK, Tseng YL, Saidman SL. Alloantibody and xenoantibody crossreactivity in transplantation. Transplantation 2004;77:1-5
29. Bottino R, Balamurugan AN, Smetanka C, et al. Isolation outcome and functional characteristics of young and adult pig pancreatic islets for transplantation studies. Xenotransplantation 2007;14:74-82 (Pubitemid 46051372)
30. van der Windt DJ, Bottino R, Casu A, et al. Long-term controlled normoglycemia in diabetic non-human primates after transplantation with hCD46 transgenic porcine islets. Am J Transplant 2009;9:2716-2726
31. Emamaullee JA, Shapiro AM, Rajotte RV, Korbutt G, Elliott JF. Neonatal porcine islets exhibit natural resistance to hypoxia-induced apoptosis. Transplantation 2006;82:945-952 (Pubitemid 44564042)
32. Korbutt GS, Elliott JF, Ao Z, Smith DK, Warnock GL, Rajotte RV. Large scale isolation, growth, and function of porcine neonatal islet cells. J Clin Invest 1996;97:2119-2129 (Pubitemid 26143967)
33. Hecht G, Eventov-Friedman S, Rosen C, et al. Embryonic pig pancreatic tissue for the treatment of diabetes in a nonhuman primate model. Proc Natl Acad Sci U S A 2009;106:8659-8664
34. Koike C, Fung JJ, Geller DA, et al. Molecular basis of evolutionary loss of the alpha 1,3-galactosyltransferase gene in higher primates. J Biol Chem 2002;277:10114-10120 (Pubitemid 34968122)
35. Dai Y, Vaught TD, Boone J, et al. Targeted disruption of the alpha1,3-galactosyltransferase gene in cloned pigs. Nat Biotechnol 2002;20:251-255 (Pubitemid 34205417)
36. Phelps CJ, Koike C, Vaught TD, et al. Production of alpha 1,3-galactosyltransferase-deficient pigs. Science 2003;299:411-414
37. Murray AG, Nelson RC, Rayat GR, Elliott JF, Korbutt GS. Neonatal porcine islet cells induce human CD4+, but not CD8+, lymphocyte proliferation and resist cell-mediated cytolytic injury in vitro. Diabetes 1999;48:1713-1719 (Pubitemid 29415188)
38. Daley SR, Cobbold SP, Waldmann H. Fc-disabled anti-mouse CD40L antibodies retain efficacy in promoting transplantation tolerance. Am J Transplant 2008;8:2265-2271
39. 1H) in cynomolgus monkeys. Am J Transplant 2010;10:773-783
40. Echeverri GJ, McGrath K, Bottino R, et al. Endoscopic gastric submucosal transplantation of islets (ENDO-STI): technique and initial results in diabetic pigs. Am J Transplant 2009;9:2485-2496
41. Fujita M, Hara H, McGrath K, et al. Technique of endoscopic biopsy of islet allografts transplanted into the gastric submucosal space in pigs. Cell Transplant. In press.
42. Christoffersson G, Henriksnäs J, Johansson L, et al. Clinical and experimental pancreatic islet transplantation to striated muscle: establishment of a vascular system similar to that in native islets. Diabetes 2010;59:2569-2578
43. Berman DM, O'Neil JJ, Coffey LC, et al. Long-term survival of nonhuman primate islets implanted in an omental pouch on a biodegradable scaffold. Am J Transplant 2009;9:91-104
44. Solari MG, Srinivasan S, Boumaza I, et al. Marginal mass islet transplantation with autologous mesenchymal stem cells promotes long-term islet allograft survival and sustained normoglycemia. J Autoimmun 2009;32:116-124
45. Dufour JM, Dass B, Halley KR, Korbutt GS, Dixon DE, Rajotte RV. Sertoli cell line lacks the immunoprotective properties associated with primary Sertoli cells. Cell Transplant 2008;17:525-534
46. Jansson L, Carlsson PO. Graft vascular function after transplantation of pancreatic islets. Diabetologia 2002;45:749-763
47. Nyqvist D, Speier S, Rodriguez-Diaz R, et al. Donor islet endothelial cells in pancreatic islet revascularization. Diabetes 2011;60:2571-2577
48. Casu A, Bottino R, Balamurugan AN, et al. Metabolic aspects of pig-tomonkey (Macaca fascicularis) islet transplantation: implications for translation into clinical practice. Diabetologia 2008;51:120-129 (Pubitemid 350197988)
49. Graham ML, Bellin MD, Papas KK, Hering BJ, Schuurman HJ. Species incompatibilities in the pig-to-macaque islet xenotransplant model affect transplant outcome: a comparison with allotransplantation. Xenotransplantation 2011;18:328-342
50. Casu A, Echeverri GJ, Bottino R, et al. Insulin secretion and glucose metabolism in alpha 1,3-galactosyltransferase knock-out pigs compared to wild-type pigs. Xenotransplantation 2010;17:131-139
51. Potter KJ, Abedini A, Marek P, et al. Islet amyloid deposition limits the viability of human islet grafts but not porcine islet grafts. Proc Natl Acad Sci USA 2010;107:4305-4310
52. U.S. Food and Drug Administration. Guidance for Industry: Source Animal, Product, Preclinical, and Clinical Issues Concerning the Use of Xenotransplantation Products in Humans. 2003. Available from: http://www.fda.gov/BiologicsBloodVaccines/ GuidanceComplianceRegulatoryInformation/Guidances/Xenotransplantation/ucm074354. htm. Accessed 12 August 2011
53. Mueller NJ, Takeuchi Y, Mattiuzzo G, Scobie L. Microbial safety in xenotransplantation. Curr Opin Organ Transplant 2011;16:201-206
54. Abrahante JE, Martins K, Papas KK, Hering BJ, Schuurman HJ, Murtaugh MP. Microbiological safety of porcine islets: comparison with source pig. Xenotransplantation 2011;18:88-93
55. Dieckhoff B, Petersen B, Kues WA, Kurth R, Niemann H, Denner J. Knockdown of porcine endogenous retrovirus (PERV) expression by PERV-specific shRNA in transgenic pigs. Xenotransplantation 2008;15:36-45 (Pubitemid 351360240)
56. Sun Y, Ma X, Zhou D, Vacek I, Sun AM. Normalization of diabetes in spontaneously diabetic cynomologus monkeys by xenografts of microencapsulated porcine islets without immunosuppression. J Clin Invest. 1996;98:1417-1422 (Pubitemid 26322067)
57. Cardona K, Korbutt GS, Milas Z, et al. Long-term survival of neonatal porcine islets in nonhuman primates by targeting costimulation pathways. Nat Med. 2006;12:304-306 (Pubitemid 43355077)
58. Cardona K, Milas Z, Strobert E, et al. Engraftment of adult porcine islet xenografts in diabetic nonhuman primates through targeting of costimulation pathways. Am J Transplant. 2007;7:2260-2268 (Pubitemid 47347856)
59. Hecht G, Eventov-Friedman S, Rosen C, et al. Embryonic pig pancreatic tissue for the treatment of diabetes in a nonhuman primate model. Proc Natl Acad Sci USA. 2009;106:8659-8664
60. Thompson P, Cardona K, Russell M, et al. CD40-specific costimulation blockade enhances neonatal porcine islet survival in nonhuman primates. Am J Transplant. 2011;11:947-957
61. Hara H, Long C, Lin YJ, et al. In vitro investigation of pig cells for resistance to human antibody-mediated rejection. Transpl Int. 2008;21:1163-1174
62. Miyagawa S, Murakami H, Takahagi Y, et al. Remodeling of the major pig xenoantigen by N-acetylglucosaminyltransferase III in transgenic pig. J Biol Chem. 2001;276:39310-39319
63. Zhou CY, McInnes E, Parsons N, et al. Production and characterization of a pig line transgenic for human membrane cofactor protein. Xenotransplantation. 2002;9:183-190 (Pubitemid 36358959)
64. Loveland BE, Milland J, Kyriakou P, et al. Characterization of a CD46 transgenic pig and protection of transgenic kidneys against hyperacute rejection in non-immunosuppressed baboons. Xenotransplantation. 2004;11:171-183 (Pubitemid 38282268)
65. White DJ, Yannoutsos N. Production of pigs transgenic for human DAF to overcome complement-mediated hyperacute xenograft rejection in man. Res Immunol. 1996;147:88-94 (Pubitemid 26180569)
66. Diamond LE, McCurry KR, Martin MJ, et al. Characterization of transgenic pigs expressing functionally active human CD59 on cardiac endothelium. Transplantation. 1996;61:1241-1249 (Pubitemid 26134777)
67. Ayares D, Phelps C, Vaught T, et al. Multi-transgenic pigs for vascularized pig organ xenografts. Xenotransplantation 2011;18:269
68. Petersen B, Ramackers W, Tiede A, et al. Pigs transgenic for human thrombomodulin have elevated production of activated protein C. Xenotransplantation. 2009;16:486-495
69. Le Bas-Bernardet S, Tillou X, Poirier N, et al. Xenotransplantation of galactosyltransferase knockout, CD55, CD59, CD39, and fucosyl-transferase transgenic pig kidneys into baboons. Transplant Proc. 2011;43:3426-3430
70. Phelps C, Ball S, Vaught T, et al. Production and characterization of transgenic pigs expressing porcine CTLA4-Ig. Xenotransplantation. 2009;16:477-485
71. Ezzelarab M, Ezzelarab C, Hara H, Ayares D, Cooper DKC. Characterization of mesenchymal stromal cells (PMSC) from GTKO pigs transgenic for CD46 and their modulatory effect on the primate cellular response. Am J Transplant 2010;10(Suppl. 4):188.
72. Weiss EH, Lilienfeld BG, Müller S, et al. HLA-E/human beta2-microglobulin transgenic pigs: protection against xenogeneic human anti-pig natural killer cell cytotoxicity. Transplantation. 2009;87:35-43
73. Petersen B, Lucas-Harn A, Lemme E, et al. Generation and characterization of pigs transgenic for human hemeoxygenase-1 (hHO-1). Xenotransplantation. 2010;17:102-103
74. Oropeza M, Petersen B, Carnwath JW, et al. Transgenic expression of the human A20 gene in cloned pigs provides protection against apoptotic and inflammatory stimuli. Xenotransplantation. 2009;16:522-534